Portage Biotech Inc (NASDAQ:PRTG) currently has a daily average trading volume of 1.35M but it saw 4178489 shares traded in last market. With a market cap of 6.85M USD, the company’s current market price of $6.11 came rising about 13.57 while comparing to the previous closing price of $5.38. In past 52 weeks, the stock remained buoying in the range of price level as high as $23.01 and as low as $2.10. In the recent trading on the day, stock has struck highest price mark of $5.41 while lowest mark touched by it was $6.84.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Oppenheimer which resumed the stock as “Outperform” in its note to investors issued on July 18, 2022, recommending a price target of $26 for it. Oppenheimer issued its recommendations for the stock as it initiated the price target for the stock is $30.
Over the week, PRTG’s stock price is moving 6.45% up while it is -22.56% when we observe its performance for the past one month. Year-to-date it is 25.72% up and over the past year, the stock is showing an upside performance of 18.18%.
The company is expected to be releasing its next quarterly report on 2024-Feb-28, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Portage Biotech Inc’s total number of outstanding shares is 1.12M with 37.24% of that held by the insiders while 4.66% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -4812.45% and return on equity (ROE) at -194.84%. Stock’s beta reads 0.63. Stock has a price to book (P/B) ratio of 4.88. Its return on asset (ROA) is -136.43% on average.
